BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:27 PM
Apr 01, 2008
 |  BC Extra  |  Clinical News

Avant's Ty800 meets typhoid endpoints

Avant (NASDAQ:AVAND) said Ty800 met the primary endpoints of safety, reactogenicity and immunogenicity in a Phase II trial to...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >